B-Type Natriuretic Peptide Testing in the Era of Neprilysin Inhibition: Are the Winds of Change Blowing?
Author(s) -
James L. Januzzi
Publication year - 2016
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2016.255455
Subject(s) - sacubitril , neprilysin , valsartan , medicine , heart failure , enalapril , ejection fraction , ace inhibitor , natriuretic peptide , cardiology , sacubitril, valsartan , angiotensin receptor , renin–angiotensin system , angiotensin converting enzyme , blood pressure , chemistry , biochemistry , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom